CDC panel to review booster for children aged 5 to 11 as U.S. cases climb 57% from two weeks ago
May 19, 2022 at 09:40 AM EDT
A Centers for Disease Control and Prevention panel will meet to review a third dose of the vaccine developed by Pfizer and BioNTech for children aged 5 to 11.
